Stimulation of Fibroblast Cell Growth, Matrix Production, and Granulation Tissue Fortnation by Connective Tissue Growth Factor

Total Page:16

File Type:pdf, Size:1020Kb

Stimulation of Fibroblast Cell Growth, Matrix Production, and Granulation Tissue Fortnation by Connective Tissue Growth Factor Stimulation of Fibroblast Cell Growth, Matrix Production, and Granulation Tissue Fortnation by Connective Tissue Growth Factor Ken Frazier, Shawn Williams, Devashish Kothapallj, Helene Klapper, and Gary R . Gwtendorst Department of Cell Biology and Anatomy, University of Miami School of Medicine, Miami. Florida. U .S.A. Connective tissue growth factor (CTGF) is a 36- to pulse labeling of cells with [35S]methionine. Subcu­ 38-kDa peptide that is selectively induced by trans­ taneous injection of TGF-J3 and CTGF into neonatal forming growth factor-J3 (TGF-J3) in fibroblastic cell NIH Swiss mice resulted in a large stimulation of types. We compared the biologic activities of CTGF granulation tissue and fibrosis at the site of injection. with TGF-J3 on fibroblasts in culture and in animal In sitll hybridization studies revealed that TGF-J3 models of fibroplasia. CTGF was active as a mitogen injection induced high levels of CTGF mRNA in the in monolayer cultures of normal rat kidney fibro­ dermal fibroblasts at the injection site, demonstrat­ blasts. CTGF did not stimulate anchorage-indepen­ ing that TGF-{3 can induce the expression of CTGF in dent growth ofNRK fibroblasts, however, or inhibit connective tissue cells ill vivo. No CTGF transcripts the growth of mink lung epithelial cells, distinguish­ were detected in the epidermal cells in either control ing CTGF's growth-regulatory activities from those or TGF-J3-injected skin or in fibroblasts in control ofTGF-J3. In NRK fibroblasts, both TGF-J3 and CTGF (saline-injected) skin. These results demonstrate that, significantly increased the transcripts encoding at like TGF-J3, CTGF can induce connective tissue cell type I collagen, as integrin, and fibronectm. Stimu­ proliferation and extracellular nlatrix synthesis. Key lation of type I collagen and fibronectin protein words: TGF-J3/collagell/wolUld 1.epairlfi/wosis. J Invest Del'­ synthesis by TGF-J3 and CTGF was confirmed by IIIatol 107:404-411, 1996 issue regeneration and repair proceed in a cascade fibroblast proli feration (DeLarco and Todaro, 1978; Assoian cf ai, fas hion beginning w ith a coagulati o n and infl amma­ 1984; Leof c/ ai, 1986; Soma and Grotendo rst, ] 989; Ishikawa e/ ,II, tOl'y phase, fo ll owed by granulation tissue formation 1990; Battegay e/ ai, 1990); (ii) elevated synthesis of extracellular and fi nally extraceIJul ar matrix deposition and termj­ matrix components inclu diJlg fibronecrin, typc I collagen, ill.tcgrins, nation of the respo nse. Peptide growth factors playa laminin, and glycosaminoglycalls productio n (Ignotz and Mas­ ceTntral role in this process. ft is li kely that f.1ctOI·S released by sague, '1986; Roberts eI ai, 1986; R aghow ct ai, 1987; Varga ct ai , pl atelets and inflamm atory cell s serve as initiators of the regenera­ 1987; Penttinen ct ai, 1988), and (iii) decrcased degradatio n of tion/repair response. Similarly, wound repair disorders, as wcll as extracellular m atrix due to direct inhibition of protease activity and organ-specifi c fibrosis, may be ca used by dysfunctional cascades. stimulation of the synthesis of protease iJlhibito rs (Laiho et ai, 1986; O ne of the principal regula tory factors that appears to function as an Lund et ai, 1987; Kerr ct ai, 1990). Previous studies have demon­ ini tiator in these processes is transforming growth factor-{3 strated that 'I large po rtion of the TGF-,B induction of matrix (TGF-(3) (Amcnto and Beck, 1991; Raghow, 1991; Wahl, 1992; protein synthesis is not shared by other growth factors such as R.oberts and Spo.", 1993). fibroblast growth factor (FGF) o r platelet deri ved growth factor TG F-{3 has been sho wn to act as a potent stimulatory signal for (PDGF) (Ignotz and Massague, 1986; R o berts el ai, 1986; Penttinen connective tissue formation during wound repair and in fibrotic et ai, 1988). conditions. Elevated TGF-{3 mRNA or protein Icvels have becn Connecti ve tissue growth factor (CTGF) is a cysteine-rich documented in tissue during normal wound repair (I garashi eI (II, mitogenic peptide that was o ri gin ally identificd as a growth factor 1993; Levine e ( ai, 1993), and fib rotic disorders ofch e skjn (Kulozik secreted by vascular endothe li al cell s in culture (Bradham el a/. et ai, 1990; Peltonen ct ai, 1990; Smith and LeRoy, 1990) and 1991 ). CTGF is selectively induced in fibroblasts aftel' acti vation internal organs and tissues (Nagy c ( ai, 1991 ; Kagami e/ ai, 1993; with TGF-{3 (Soma and Grotcndo rst, 1989; Igarashi ef ai, 1993). Bahadori et ai, 1995). T he increased fi brotic tiss ue has been CTGF is a m ember of a tamily of peptides that include serum­ attributed to severa l actions of TGF- {3, including: (i) increased induced gene products ceftO (Simmons et ai, 1989), cyr61 (O'Bri en et ai, 1990), flsp1 2/ {31G M 1 (Brunner el ai, 1991; R yseck et ai , '1991) Manuscript received February 23, 1996; revised April 29, 1996; accepted and a chi cken transforming gene, nov Oo li ot et 1992). CTGF fo r publication May 21.1 996. ai, Reprint requests to: Dr. Gary R . Grotcndorst, Department of Cdl also shares significant sequence homology w ith a Drosophila gene Biology and Anatomy, University of Miami School of Medicin e (R-124), product, twisted gastrulation (twg) (Mason et ai, 1994), that 1600 NW 10th Avenue, Miami, FL 33'136. determines cell fates during do rsa l/ventral pa ttern formation in the Abbreviations: CTGF, connective ti ss ue growth fa ctor; r TGF, recom­ cmbryo. Previo us studies have dcmonstratcd coordinate expression binant connective tisslI e growth flletor. of TGF-,Bl and CTGF in granul;ltion tiss ue bcds during wound 0022-202X/96/S10.50 • Copyri ght lid 1996 by T he Society for In vestigative Dermatology, Ill c. 404 VOL. 107, NO.3 SEPTEMB ER 19% e T C I: STIMULATION OF FIBROPLASIA 405 repair (Igarashi el n/, 1993) and found th at d e rmal fibroblasts in 49F fibroblasts as ta rget cell s as described previously (Soma and Groten­ sc1et-o d erma lesions overexpress CTGF (Ig arashi c( (/ 1, 1995). T h e do rst, 1989). Anchorage-independent growth assays 'were pcrfornlcd essen­ CTGF mRNA is selectively induced in fibroblasts b y TGF- {3, but tia ll y as described by Guadagno and Assoian (1991). not by oth e r g rowth fa c tors, su c h as epiderm a l growth f.,cto r Growth Inhibition Assays T he mink lung epithelial cell line. Mv1Lu (EGF), PDGF, or FGFs (acidic FGF, basic .FGF) (Igarashi el n/, (ATTC No. CCL 64), was used as C<l.rget for growth-inhibitory assays with 1993)- Prote in synthesis is n ot required for TGF-{3 stimulation of TGF-{3 and CTGF. Assays were perfomled as described by Ogawa and CTGF gen e expressio n (Igarashi eI aI, 1993; G rotendorst c( ai, Seyedin (1991). 1996), indicating that the CTGF gen e is directly regulate d by Extracellular Matrix Protein mRNA Induction Assays NRK rat TGF-/3- We h ave now ide n tifi e d a n ovel TGF-/3 resp o n se e le m e nt fibro blasts 'were g ro\vn to conRucn cc in DMEM \~' i th 50/0 feta] b ovin e serun1 (T/3RE) in th e CTGF promoter (Grotendorst c( n/, 1996), w hic h and then serum starved in DMEM with 1% bovine serum albumin for 24 h. begins to define the molecular basis for the selective regulation of Growth f.,cto rs were added to the cell cultures; tota'! cellular RNA was tills gene by TGF-/3_ T h e T/3RE seque n ce present in th e human and extracted after 24 h, and northern blot analysis was perfonn ed as described mou se CTGF genes is not prese nt in the promote rs o f other previously (I garas hi el ai, 1993)_ To ensure that equ.ivalent amo unts of total TGF-f3-regulate d gene that h as b een d escribed to d a te . RNA were added to each lane on a gel, RNA was quantitated by AU ,O / 2S" ratios. and equi valent transfer was ass UJ:ed by comparing ribosom al 28S and Becau se of the pleiotropic action s of TGF-/3 on cells and the 18S RNA bands in each lane after stai ning with ethi dium bromide. As an selective induction ofCTGF by TGF-/3 in fibroblasts, w e wanted to additional con trol, blo ts we re reprobed with an actin cDNA probe. c ompare th e biolog ic activities of CTGF with TGF-/3- Until n ow, Double- stranded cDNA fi'agments used for probes were labeled with the limite d availability of n at m al CTGF made it difficult to p e rform ,n pjdCTP using a ra ndom prime labeling kit (Boehri nger Mannheim. studies o n the biolog ic ac tions of thc m o lecule_ We h ave produced Indianapolis. IN). T he CTGF probe was derived frOI11 a l.l - kb human recombinant CTGF to address this questio n . O ur studies indicate cDNA tragment that encompassed the open reading frame of the CTGF that r ecombina n t CTGF is mitogenic for NRJ< fibroblasts in transcript. T he TGF- f31 probe w as a 1.0-kb Narr fragment derived fro m a monolayer c ulture. TGF- /3 in th e presen ce of EGF and serum is 2.0-kb human TGF-f31 cDNA presen t (G.
Recommended publications
  • Tendon Fibroblasts
    Ann Rheum Dis: first published as 10.1136/ard.46.5.385 on 1 May 1987. Downloaded from Annals of the Rheumatic Diseases, 1987; 46, 385-390 Isolation and growth characteristics of adult human tendon fibroblasts M D CHARD, J K WRIGHT, AND B L HAZLEMAN From the Rheumatology Research Unit, Addenbrooke's Hospital, Hills Road, Cambridge SUMMARY An explant method for the isolation of fibroblasts from adult human tendon is described. Cells were successfully isolated from 22 out of 27 common biceps tendons obtained from cadaveric donors (age range 11-83 years). The fibroblasts could be maintained in culture using standard methods and morphologically resembled those of synovial rather than dermal origin. Growth characteristics of 12 cell lines were assessed by deoxyribose nucleic acid (DNA) synthesis using [3H]thymidine incorporation in response to stimulation by fetal calf serum. Cells obtained separately from superficial and deep parts of the tendons produced almost identical responses. No significant reduction in growth response with increasing age was found when related to the age of the donor. Therefore this study did not show any age related defect in the short term tendon fibroblast replicative responses to serum. Key words: in vitro, DNA synthesis. copyright. Tendinous lesions are common, but their nature and other tissues such as skin. It is desirable to investi- any possible predisposing factors are not well gate adult human tendon fibroblasts directly. It was understood. They occur in middle life frequently thought that the culture of adult human tendon after only minor, if any, injury. The extent to which fibroblasts would be very difficult to achieve be- this reflects age related changes in tendon tissue is cause of the differentiated appearance of cells on uncertain.
    [Show full text]
  • Nomina Histologica Veterinaria, First Edition
    NOMINA HISTOLOGICA VETERINARIA Submitted by the International Committee on Veterinary Histological Nomenclature (ICVHN) to the World Association of Veterinary Anatomists Published on the website of the World Association of Veterinary Anatomists www.wava-amav.org 2017 CONTENTS Introduction i Principles of term construction in N.H.V. iii Cytologia – Cytology 1 Textus epithelialis – Epithelial tissue 10 Textus connectivus – Connective tissue 13 Sanguis et Lympha – Blood and Lymph 17 Textus muscularis – Muscle tissue 19 Textus nervosus – Nerve tissue 20 Splanchnologia – Viscera 23 Systema digestorium – Digestive system 24 Systema respiratorium – Respiratory system 32 Systema urinarium – Urinary system 35 Organa genitalia masculina – Male genital system 38 Organa genitalia feminina – Female genital system 42 Systema endocrinum – Endocrine system 45 Systema cardiovasculare et lymphaticum [Angiologia] – Cardiovascular and lymphatic system 47 Systema nervosum – Nervous system 52 Receptores sensorii et Organa sensuum – Sensory receptors and Sense organs 58 Integumentum – Integument 64 INTRODUCTION The preparations leading to the publication of the present first edition of the Nomina Histologica Veterinaria has a long history spanning more than 50 years. Under the auspices of the World Association of Veterinary Anatomists (W.A.V.A.), the International Committee on Veterinary Anatomical Nomenclature (I.C.V.A.N.) appointed in Giessen, 1965, a Subcommittee on Histology and Embryology which started a working relation with the Subcommittee on Histology of the former International Anatomical Nomenclature Committee. In Mexico City, 1971, this Subcommittee presented a document entitled Nomina Histologica Veterinaria: A Working Draft as a basis for the continued work of the newly-appointed Subcommittee on Histological Nomenclature. This resulted in the editing of the Nomina Histologica Veterinaria: A Working Draft II (Toulouse, 1974), followed by preparations for publication of a Nomina Histologica Veterinaria.
    [Show full text]
  • Brown Adipose Tissue: New Challenges for Prevention of Childhood Obesity
    nutrients Review Brown Adipose Tissue: New Challenges for Prevention of Childhood Obesity. A Narrative Review Elvira Verduci 1,2,*,† , Valeria Calcaterra 2,3,† , Elisabetta Di Profio 2,4, Giulia Fiore 2, Federica Rey 5,6 , Vittoria Carlotta Magenes 2, Carolina Federica Todisco 2, Stephana Carelli 5,6,* and Gian Vincenzo Zuccotti 2,5,6 1 Department of Health Sciences, University of Milan, 20146 Milan, Italy 2 Department of Pediatrics, Vittore Buzzi Children’s Hospital, University of Milan, 20154 Milan, Italy; [email protected] (V.C.); elisabetta.diprofi[email protected] (E.D.P.); giulia.fi[email protected] (G.F.); [email protected] (V.C.M.); [email protected] (C.F.T.); [email protected] (G.V.Z.) 3 Pediatric and Adolescent Unit, Department of Internal Medicine, University of Pavia, 27100 Pavia, Italy 4 Department of Animal Sciences for Health, Animal Production and Food Safety, University of Milan, 20133 Milan, Italy 5 Department of Biomedical and Clinical Sciences “L. Sacco”, University of Milan, 20157 Milan, Italy; [email protected] 6 Pediatric Clinical Research Center Fondazione Romeo ed Enrica Invernizzi, University of Milan, 20157 Milan, Italy * Correspondence: [email protected] (E.V.); [email protected] (S.C.) † These authors contributed equally to this work. Abstract: Pediatric obesity remains a challenge in modern society. Recently, research has focused on the role of the brown adipose tissue (BAT) as a potential target of intervention. In this review, we Citation: Verduci, E.; Calcaterra, V.; revised preclinical and clinical works on factors that may promote BAT or browning of white adipose Di Profio, E.; Fiore, G.; Rey, F.; tissue (WAT) from fetal age to adolescence.
    [Show full text]
  • Tendon Healing with Allogenic Fibroblast and Static Magnetic Field in Rabbit Model
    IJVS 2015; 10(2); Serial No:23 IRANIAN JOURNAL OF VETERINARY SURGERY (IJVS) WWW.IVSA.IR Tendon Healing with Allogenic Fibroblast and Static Magnetic Field in Rabbit Model Amin Bigham-Sadegh*1, Setare Ghasemi 2, Iraj Karimi 3, Pezhman Mirshokraei 4, Hasan Nazari 5, Ahmad Oryan 6 Abstract Objectives- Tendons are integral parts of musculoskeletal system and are subjected to injury. Fibroblast is used in tendon healing, however, there is no proved and reported result regarding concurrent use of allogenic fibroblast with static magnetic field in tendon healing. In addition, there are some studies done on the effect of magnetic fields on tendon healing but the results are antithesis. The aim of this study is to evaluate the effect of simultaneous application of fibroblast and magnetic field on tendon healing in rabbit model. Design- Experimental study. Animals- Eighteen female rabbits, 15 months old and weighing 3.0±0.5 kg were used in this study. Procedures- Two legs of eighteen rabbits were divided into 6 groups. After skin incision, superficial flexor tendon was exposed and cut transversely and then sutured. In control group tendon injury were created in right and left legs and sutured in bunnell mayer suturing technique. In culture media substance group after tendon injury in two legs, 0.5 cc culture substance was injected in the injured tendon area in two legs. In fibroblast group, fibroblast cells were injected in the tendon injured area in both legs. Then all injuries legs were dressed up, a piece of magnet was placed in the surrounding bandage of the left leg for 7 days and right legs were left empty.
    [Show full text]
  • White Adipocyte Plasticity in Physiology and Disease
    cells Review White Adipocyte Plasticity in Physiology and Disease Ewa Bielczyk-Maczynska Department of Chemical and Systems Biology, Stanford University, Stanford, CA 94305, USA; [email protected] Received: 19 October 2019; Accepted: 21 November 2019; Published: 25 November 2019 Abstract: Cellular plasticity is a transformation of a terminally differentiated cell into another cell type, which has been long known to occur in disease and regeneration. However, white adipocytes (fat cells) have only recently been observed to undergo different types of cellular plasticity. Adipocyte transdifferentiation into myofibroblasts and cancer-associated fibroblasts occurs in fibrosis and cancer, respectively. On the other hand, reversible adipocyte dedifferentiation into adipocyte progenitor cells (preadipocytes) has been demonstrated in mammary gland and in dermal adipose tissue. Here we discuss the research on adipocyte plasticity, including the experimental approaches that allowed to detect and study it, the current state of the knowledge, major research questions which remain to be addressed, and the advances required to stimulate adipocyte plasticity research. In the future, the knowledge of the molecular mechanisms of adipocyte plasticity can be utilized both to prevent adipocyte plasticity in disease and to stimulate it for use in regenerative medicine. Keywords: cell plasticity; adipocytes; fat; cell dedifferentiation; cell transdifferentiation; cell differentiation 1. Introduction In the traditional view of cell differentiation, cells follow a differentiation trajectory in discrete developmental stages, beginning with stem cells and culminating with a terminally differentiated state [1]. The terminally differentiated state is thought to be permanent as the cells can no longer transfer into other cell fates. However, in many systems the phenomenon of cellular plasticity, which is a transformation of a cellular phenotype beginning with a terminally differentiated cell, has been described not only in pathologies like cancer, but also during physiological processes [2].
    [Show full text]
  • Extracellular Matrix Regulates Fibroblast Heterogeneity and Tumorigenesis
    University of Pennsylvania ScholarlyCommons Publicly Accessible Penn Dissertations 2017 Extracellular Matrix Regulates Fibroblast Heterogeneity And Tumorigenesis Diana Leigh Avery University of Pennsylvania, [email protected] Follow this and additional works at: https://repository.upenn.edu/edissertations Part of the Cell Biology Commons, Oncology Commons, and the Pharmacology Commons Recommended Citation Avery, Diana Leigh, "Extracellular Matrix Regulates Fibroblast Heterogeneity And Tumorigenesis" (2017). Publicly Accessible Penn Dissertations. 2173. https://repository.upenn.edu/edissertations/2173 This paper is posted at ScholarlyCommons. https://repository.upenn.edu/edissertations/2173 For more information, please contact [email protected]. Extracellular Matrix Regulates Fibroblast Heterogeneity And Tumorigenesis Abstract Heterogeneous activated fibroblasts that deposit and remodel extracellular matrix (ECM) comprise desmoplasia, a key regulator of tumor development. The divergent outcomes in response to varied therapies targeting intratumoral desmoplasia underscore the pressing need to delineate the intricate role of a heterogeneous stroma in tumorigenesis. Fibroblast activation protein (FAP) and alpha-smooth muscle actin (αSMA) identify distinct, yet overlapping, activated fibroblast subsets in myriad tumor types, fibrosis, and wound healing. FAPHi reactive fibroblasts and αSMAHi myofibroblasts can exert divergent influences on tumor progression. However, the factors that drive this phenotypic heterogeneity and the
    [Show full text]
  • Fibroblast-Derived Extracellular Matrix: an Alternative Cell Culture Substrate That Alters Lung Cancer Cell Line Phenotype
    University of Louisville ThinkIR: The University of Louisville's Institutional Repository Electronic Theses and Dissertations 6-2015 Fibroblast-derived extracellular matrix: an alternative cell culture substrate that alters lung cancer cell line phenotype. Michael Thomas Scherzer University of Louisville Follow this and additional works at: https://ir.library.louisville.edu/etd Part of the Biomedical Engineering and Bioengineering Commons Recommended Citation Scherzer, Michael Thomas, "Fibroblast-derived extracellular matrix: an alternative cell culture substrate that alters lung cancer cell line phenotype." (2015). Electronic Theses and Dissertations. Paper 1995. https://doi.org/10.18297/etd/1995 This Master's Thesis is brought to you for free and open access by ThinkIR: The University of Louisville's Institutional Repository. It has been accepted for inclusion in Electronic Theses and Dissertations by an authorized administrator of ThinkIR: The University of Louisville's Institutional Repository. This title appears here courtesy of the author, who has retained all other copyrights. For more information, please contact [email protected]. FIBROBLAST-DERIVED EXTRACELLULAR MATRIX: AN ALTERNATIVE CELL CULTURE SUBSTRATE THAT ALTERS LUNG CANCER CELL LINE PHENOTYPE By Michael Thomas Scherzer B.S., University of Louisville A Thesis Submitted to the Faculty of the University of Louisville J.B Speed School of Engineering As Partial Fulfillment of the Requirements For the Professional Degree MASTER OF ENGINEERING Department of Bioengineering June 2015 i ii FIBROBLAST-DERIVED EXTRACELLULAR MATRIX: AN ALTERNATIVE CEL CULTURE SUBSTRATE THAT ALTERS LUNG CANCER CELL LINE PHENOTYPE Submitted by: __________________________________ Michael T. Scherzer A Thesis Approved On ___________________________________ (Date) By the Following Reading and Examination Committee ___________________________________ Dr.
    [Show full text]
  • Chondrogenesis, Studied with the Electron Microscope
    CHONDROGENESIS, STUDIED WITH THE ELECTRON MICROSCOPE GABRIEL C. GODMAN, M.1)., and KEITH R. PORTER, Ph.I). From The Rockefeller Institute. Dr. Godman's present address is Department of Microbiology, Columbia University, New York ABSTRACT The role of the cells in the fabrication of a connective tissue matrix, and the structural modifications which accompany cytodifferentiation have been investigated in developing epiphyseal cartilage of fetal rat by means of electron microscopy. Differentiation of the pre- chondral mesenchymal cells to chondroblasts is marked by the acquisition of an extensive endoplasmic reticulum, enlargement and concentration of the Golgi apparatus, the ap- pearance of membrane-bounded cytoplasmic inclusions, and the formation of specialized foci of increased density in the cell cortex. These modifications are related to the secretion of the cartilage matrix. The matrix of young hyaline cartilage consists of groups of rela- tively short, straight, banded collagen fibrils of 10 to 20 m# and a dense granular component embedded in an amorphous ground substance of moderate electron density. It is postu- lated that the first phase of fibrillogenesis takes place at the cell cortex in dense bands or striae within the ectoplasm subjacent to the cell membrane. These can be resolved into sheaves of "primary" fibrils of about 7 to 10 m#. They are supposedly shed (by excortica- tion) into the matrix space between the separating chondroblasts, where they may serve as "cores" of the definitive matrix fibrils. The diameter of the fibrils may subsequently increase up to threefold, presumably by incorporation of "soluble" or tropocollagen units from the ground substance. The chondroblast also discharges into the matrix the electron- dense amorphous or granular contents of vesicles derived from the Golgi apparatus, and the mixed contents of large vacuoles or blebs bounded by distinctive double membranes.
    [Show full text]
  • Organ-Specific, Fibroblast-Derived Matrix As a Tool for Studying Breast
    cancers Article Organ-Specific, Fibroblast-Derived Matrix as a Tool for Studying Breast Cancer Metastasis Adina R. D. Jensen 1,†, Edward R. Horton 1,†, Lene H. Blicher 2, Elin J. Pietras 1, Cornelia Steinhauer 1, Raphael Reuten 1 , Erwin M. Schoof 2 and Janine T. Erler 1,* 1 Biotech Research and Innovation Centre (BRIC), University of Copenhagen (UCPH), 2200 Copenhagen, Denmark; [email protected] (A.R.D.J.); [email protected] (E.R.H.); [email protected] (E.J.P.); [email protected] (C.S.); [email protected] (R.R.) 2 Department of Biotechnology and Biomedicine, Technical University of Denmark, 2800 Lyngby, Denmark; [email protected] (L.H.B.); [email protected] (E.M.S.) * Correspondence: [email protected] † These authors contributed equally to this study. Simple Summary: Cancer in the breast often spreads to other parts of the body, such as the lungs, which leads to poor outcomes for patients, as there are few effective treatments. Within organs such as the lungs, cancer cells are surrounded by a scaffold, made of proteins, which helps keeps the organs’ structure and maintains their function. This scaffold is produced by cells called fibroblasts, and we can reproduce this in the lab. We aim to investigate how cancer cells interact with the protein scaffold from different organs, where breast cancer cells spread to. This study hopes to reveal how breast cancer reacts to different organ environments and use this method to perform large-scale drug screening. Importantly, this study has shown that drug testing of breast cancer cells within a more Citation: Jensen, A.R.D.; physiological context, as opposed to testing on plastic, can lead to increased identification of targets Horton, E.R.; Blicher, L.H.; to treat breast cancer.
    [Show full text]
  • Dietary N-3 Long-Chain Polyunsaturated Fatty Acids
    Worsch et al. Nutrition & Metabolism (2018) 15:65 https://doi.org/10.1186/s12986-018-0291-x RESEARCH Open Access Dietary n-3 long-chain polyunsaturated fatty acids upregulate energy dissipating metabolic pathways conveying anti- obesogenic effects in mice Stefanie Worsch1,2, Mathias Heikenwalder4, Hans Hauner1,2,3 and Bernhard L. Bader1,2,3* Abstract Background: We previously reported on the anti-obesogenic and anti-inflammatory effects associated with n-3 long-chain polyunsaturated fatty acids (LCPUFA) in our diet-induced obesity (DIO) mouse model. Two isocaloric high-fat diets (HFDs; 48 kJ% fat), HFD (HF) and n-3 LCPUFA-enriched HFD (HF/n-3), and a control diet (C; 13 kJ% fat) were used. The underlying mechanisms however have largely remained unclear. Here, we assessed whether the reduced fat mass reflected n-3 LCPUFA-induced expression changes in lipid metabolism of the intestine, liver, and interscapular brown adipose tissue (iBAT), as well as increased iBAT thermogenic capacity. Methods: For HF/n-3, saturated and monounsaturated fatty acids were partially substituted by n-3 LCPUFA eicosapentaenoic acid and docosahexaenoic acid to achieve a balanced n-6/n-3 PUFA ratio (0.84) compared to the unbalanced ratios of HF (13.5) and C (9.85). Intestine, liver and iBAT from male C57BL/6 J mice, fed defined soybean/palm oil-based diets for 12 weeks, were further analysed. Gene and protein expression analyses, immunohistochemistry and correlation analyses for metabolic interactions were performed. Results: Compared to HF and C, our analyses suggest significantly diminished de novo lipogenesis (DNL) and/or increased hepatic and intestinal fatty acid oxidation (ω-oxidation and peroxisomal β-oxidation) in HF/n-3 mice.
    [Show full text]
  • LABORATORY 6 - CONNECTIVE TISSUE (First of Three Laboratory Sessions)
    LABORATORY 6 - CONNECTIVE TISSUE (first of three laboratory sessions) Throughout the course, you will see connective tissue on virtually every slide, since connective tissue occurs under all epithelia. In order to acquire an initial understanding of the appearance and variety of connective tissues, you will first look at several types of soft connective tissue in the light microscope and in electron micrographs. During the second laboratory session you will study a few of the more specialized connective tissues and the three types of cartilage. The structure of bone is rather complicated and we will consider its development, mature structure and maintenance on a third day. OBJECTIVES: LIGHT MICROSCOPY - Recognize types of soft and hard connective tissues including the cell types, fibers and matrix that each contains. Understand how the structure of connective tissues and their components are related to function. ELECTRON MICROSCOPY - In soft and hard connective tissues recognize the cell types and fibers and know their characteristics. ASSIGNMENT FOR TODAY'S LABORATORY GLASS SLIDES SL 1 (Spread) Loose connective tissue (areolar) SL 91 (Salivary gland) Loose to dense irregular connective tissue SL 25 (Skin) Dense irregular connective tissue SL 24 (Bronchus) Loose to dense irregular C.T. SL 118 (Esophagus - stomach) - Mast cells in C.T. SL 27 (Tendon) Dense regular C.T. SL 184 (Large artery) Elastic C.T. - resorcin stained SL 31 (Large elastic artery) Elastic C.T. ELECTRON MICROGRAPHS EM 15 Elastin and collagen EM 21-4 Fibroblasts POSTED ELECTRON MICROGRAPHS #10 Connective tissue fibers #14 Basal lamina #15 Mast cell #29 Cytochemical method Lab 6 Posted EMs; Lab 6 Posted EMs with some yellow labels HISTOLOGY IMAGE REVIEW - available on computers in HSL Chapter 5.
    [Show full text]
  • Fibroblast Aftercare Instructions
    weeks before your treatment, espe- cially if you are naturally darker FIBROBLAST skinned. You may even wish to con- sider using a natural Tyrosinase AFTERCARE Inhibitor to helps ensure there is no INSTRUCTIONS overproduction of pigment in the skin aka hyperpigmentation. Like most skin rejuvenation treat- 2. Avoid any other type of proce- ments, there may be some side-ef- dures on the same area which you fects post-treatment and recovery intend to have treated with Fibro- from Fibroblast. You must follow these blast, such as laser therapy, chemi- important guidelines carefully if you cal peels, Botox, fillers, as this may wish to enjoy optimal results and prevent your treatment being per- protect your investment in Fibroblast formed by your technician at the treatment. time you want it. Although for most Fibroblast treat- • No facial acids (Retin A, salicylic, ment is virtually pain-free, your own glycolic) 14 days before or 21 treatment may be moderately un- days after Fibroblast. comfortable and sensitive depend- • No Botox or fillers 21 days before ing on where you are being treated or after Fibroblast. – especially eyelid procedures • No Micro needling/PRP 21 days where the skin is at its thinnest – and before or after Fibroblast. your own sensitivities and tolerances. • No laser or peels (depending on intensity of peel) for 90 days before Before Your Treatment or after Fibroblast. • Surgical procedures like face lifts 1. Avoid any kind of tanning (Spray you must wait at least 9 months tanning, tanning injections, sun tan- postop/before Fibroblast. ning and tanning beds) for 2 to 4 Salon D’ Shayn | 1616 N.
    [Show full text]